Recent research has confirmed that miRNAs can modulate the multidrug resistance of many cancer cells; [45], [46], [47] for instance, Zhu et al [48] found that mir-181b modulates multidrug resistance by targeting Bcl2 in human cancer cell lines. Here, BCL2 is linked to cancer.